{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:09:42Z","timestamp":1791050982998,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,8,1]],"date-time":"1992-08-01T00:00:00Z","timestamp":712627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Arch Occup Environ Heath"],"published-print":{"date-parts":[[1992,8]]},"DOI":"10.1007\/bf00381477","type":"journal-article","created":{"date-parts":[[2004,11,7]],"date-time":"2004-11-07T06:06:40Z","timestamp":1099807600000},"page":"105-112","source":"Crossref","is-referenced-by-count":212,"title":["Occupational exposure to antineoplastic agents at several departments in a hospital"],"prefix":"10.1007","volume":"64","author":[{"given":"P. J. M.","family":"Sessink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. A.","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P. H.","family":"Scheefhals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. B. M.","family":"Anzion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"1033","volume":"47","author":"American Society of Hospital Pharmacists","year":"1990","unstructured":"American Society of Hospital Pharmacists (1990) ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm 47:1033?1049","journal-title":"Am J Hosp Pharm"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(87)90490-6","volume":"83","author":"GL Baker","year":"1987","unstructured":"Baker GL, Kahl LE, Zee BC, Stelzer BL, Agarwal AK, Medsger Jr TA (1987) Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term casecontrol follow-up study. Am J Med 83:1?9","journal-title":"Am J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00380766","volume":"58","author":"CTA Evelo","year":"1986","unstructured":"Evelo CTA, Bos RP, Peters JGP, Henderson PT (1986) Urinary cyclophosphamide assay as a method for biological monitoring of occupational exposure to cyclophosphamide. Int Arch Occup Environ Health 58:151?155","journal-title":"Int Arch Occup Environ Health"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0277-5379(86)90045-3","volume":"22","author":"U Friederich","year":"1986","unstructured":"Friederich U, Molko F, Hofmann V, Scossa D, Hann D, W\u00fcrgler FE, Senn HJ (1986) Limitations of the Salmonellal mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs. Eur J Cancer Clin Oncol 22:567?575","journal-title":"Eur J Cancer Clin Oncol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-105-3-360","volume":"105","author":"MH Greene","year":"1986","unstructured":"Greene MH, Harris EL, Gershenson DM, et al. (1986) Melphalan may be a more potent leukemogen than cyclophosphamide. Ann Intern Med 105:360?367","journal-title":"Ann Intern Med"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/bjc.1987.40","volume":"55","author":"JF Haas","year":"1987","unstructured":"Haas JF, Kittelmann B, Mehnert WH, Staneczek W, M\u00f6hner M, Kaldor JM, Day NE (1987) Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br J Cancer 55:213?218","journal-title":"Br J Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0140-6736(84)92111-1","volume":"1","author":"M Hirst","year":"1984","unstructured":"Hirst M, Tse S, Mills DG, Levin L, White DF (1984) Occupational exposure to cyclophosphamide. Lancet 1:186?188","journal-title":"Lancet"},{"key":"CR8","volume-title":"Personal report","author":"IMS Holland","year":"1989","unstructured":"IMS Holland (1989) Personal report. Instituut voor Medische Statistiek, The Hague, The Netherlands"},{"key":"CR9","unstructured":"International Agency for Research on Cancer (1981) IARC monographs on the evaluation of the carcinogenic risk to humans, vol 26. Some antineoplastic and immunosuppressive agents. Lyon, France"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199001043220101","volume":"322","author":"JM Kaldor","year":"1990","unstructured":"Kaldor JM, Day NE, Pettersson F, et al. (1990) Leukemia following chemotherapy for ovarian cancer. N Engl J Med 322:1?6","journal-title":"N Engl J Med"},{"key":"CR11","first-page":"1942","volume":"43","author":"MA McDiarmid","year":"1986","unstructured":"McDiarmid MA, Egan T, Furio M, Bonacci M, Watts SR (1986) Sampling for airborne fluorouracil in a hospital drug preparation area. Am J Hosp Pharm 43:1942?1945","journal-title":"Am J Hosp Pharm"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-103-2-195","volume":"103","author":"J Pedersen-Bjergaard","year":"1985","unstructured":"Pedersen-Bjergaard J, Ersb\u00f8ll J, S\u00f8rensen HM, et al. (1985) Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Ann Intern Med 103:195?200","journal-title":"Ann Intern Med"},{"key":"CR13","first-page":"16","volume":"14","author":"PJM Sessink","year":"1992","unstructured":"Sessink PJM, Anzion RB, van den Broek PHH, Bos RP (1992) Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharm Weekbl [Sci] 14:16?22","journal-title":"Pharm Weekbl [Sci]"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/jat.2550110210","volume":"11","author":"PJM Sessink","year":"1991","unstructured":"Sessink PJM, van den Broek PHH, Bos RP (1991) Urinary cyclophosphamide excretion in rats after intratracheal, dermal, oral and intravenous administration of cyclophosphamide. J Appl Toxicol 11:125?128","journal-title":"J Appl Toxicol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0165-1110(85)90024-7","volume":"154","author":"M Sorsa","year":"1985","unstructured":"Sorsa M, Hemminki K, Vainio H (1985) Occupational exposure to anticancer drugs ? potential and real hazards. Mutat Res 154:135?149","journal-title":"Mutat Res"},{"key":"CR16","first-page":"1163","volume":"40","author":"MH Stolar","year":"1983","unstructured":"Stolar MH, Power LA, Viele CS (1983) Recommendations for handling cytotoxic drugs in hospitals. Am J Hosp Pharm 40:1163?1171","journal-title":"Am J Hosp Pharm"},{"key":"CR17","first-page":"597","volume":"40","author":"A deWerk Neal","year":"1983","unstructured":"deWerk Neal A, Wadden RA, Chiou WL (1983) Exposure of hospital workers to airborne antineoplastic agents. Am J Hosp Pharm 40:597?601","journal-title":"Am J Hosp Pharm"}],"container-title":["International Archives of Occupational and Environmental Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00381477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00381477\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00381477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T21:35:01Z","timestamp":1554327301000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00381477"}},"subtitle":["Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers"],"short-title":[],"issued":{"date-parts":[[1992,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,8]]}},"alternative-id":["BF00381477"],"URL":"https:\/\/doi.org\/10.1007\/bf00381477","relation":{},"ISSN":["0340-0131","1432-1246"],"issn-type":[{"value":"0340-0131","type":"print"},{"value":"1432-1246","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,8]]}}}